Phase 4 N=60 Study of the Efficacy of Cloderm® Cream in the Treatment of Moderate Plaque Psoriasis
Psoriasis
Primary: Investigator's Global Assessment (IGA) — 15 percentage of subjects
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=376 A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension
Glaucoma, Open-Angle · Ocular Hypertension
Primary: Change From Baseline in Intraocular Pressure (IOP) in the Study Eye — 25.4; -6.3 Millimeters of Mercury (mmHg)
Phase 4 N=95 A Study of Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis
Rheumatoid Arthritis
Primary: Percentage of Participants Reporting Any Adverse Event - Overall Summary of Events — 8.4; 0; 38.9; 45.3 percentage of participants
Phase 4 N=219 A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264)
Osteoporosis, Postmenopausal
Primary: Base Study: Percentage Change From Baseline in Lumbar Spine Bone Mineral Density (BMD) at Month 6 — 3.54; 1.59 Percent change — p=<0.001
Phase 4 N=697 Evaluation of Integrated Cardiac Imaging in Ischemic Heart Disease
Ischemic Heart Disease
Primary: Diagnosis of IHD at Invasive Coronary Angiography and FFR Measurement — 140 participants
Phase 4 N=87 A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension
Glaucoma, Open-Angle · Ocular Hypertension
Primary: Change From Baseline in Intraocular Pressure (IOP) in the Study Eye — 22.2; -6.7 Millimeters of Mercury (mmHg)
Phase 4 N=28 Ziprasidone in Pediatric Bipolar Disorder
Bipolar Disorder
Primary: Young Mania Rating Scale (YMRS) — 12.70; 12.57 units on a scale
Phase 4 N=96 Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants
Meconium Ileus · Very Low Birth Weight Infant
Primary: Time to Complete Meconium Evacuation in Days — 7; 8 days of life — p=0.61
Phase 4 N=306 Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis
Active Rheumatoid Arthritis · Arthritis, Rheumatoid · Rheumatoid Arthritis
Primary: Number of Participants That Met Sustained Remission at Week 76 and Week 91 Based on DAS28 Score — 40; 26; 15 Participants — p=<0.0001
Phase 4 N=213 Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)
Chronic Kidney Disease · Renal Insufficiency
Primary: Capture of Post-marketing Safety Information in Patients With Moderate Renal Insufficiency Undergoing Routine Contrast-enhanced MRI With Administration of OMNISCAN in…
Phase 4 N=94 Oral Nutrition After Regular Radical Cystectomy
Post Cystostomy
Primary: the Postoperative Length of Stay — 18; 14 day — p=<0.001
Phase 4 N=755 Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)
Rheumatoid Arthritis
Primary: Disease Activity Score Erythrocyte Sedimentation Rate(DAS28-ESR) — 3.0; 2.9; 3.1; 2.8 Scores on a scale
Phase 4 N=41 NasoNeb Delivery of an Intranasal Steroid
Perennial Allergic Rhinitis
Primary: Change in Nasal Peak Inspiratory Flow (NPIF) — 36.41; 18.71 liters/min
Phase 4 N=61 Randomized Controlled Trial of Surfactant Delivery Via Laryngeal Mask Airway (LMA) Versus Endotracheal Intubation
Respiratory Distress Syndrome, Newborn
Primary: Rate of Failure of Surfactant Therapy, Either Early (Need for Mechanical Ventilation Within 1 Hour), or Late (FiO2 > 0.60 to Maintain Target SpO2, or Second Dose of…
Phase 4 N=31 Efficacy & Safety of Eszopiclone (Lunesta) in Nursing Home Patients
Poor Quality Sleep
Primary: Sleep Efficiency — 70.0; 65.8 percentage of sleep